Hilde Windels
Independent Director
Ablynx
Belgium
Biography
Mrs. Windels is currently an Executive Director of Biocartis Group NV, and a member of the board of directors of Erytech Pharma SA and Vlaams Instituut voor Biotechnologie (VIB). She has approximately 20 years of experience in the biotechnology field with a track record of building and structuring organisations, private fundraising, M&A, capital markets and business and corporate strategy. Mrs. Windels served as CFO for Biocartis NV from 2011 until she became Deputy CEO in 2015, followed by a CEO ad interim position in 2017. From 2009 to 2011, she worked as an independent CFO for several private biotech companies. From 1999 to 2008, Mrs. Windels was CFO and a board member of Devgen NV.
Research Interest
Biology, Genetics and Gene expression
